Immunology

M.J. Elices, L. Osborn, Y. Takada, C. Crouse, et al., "VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site," Cell, 6:577-84, 1990. Mariano J. Elices (Dana-Farber Cancer Institute, Boston): "The ability of leukocytes to migrate through the body is an essential underpinning for normal immune surveillance and relies on a dynamic interaction between circulating leukocytes and the endothelium. The leukocyte integrin


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

M.J. Elices, L. Osborn, Y. Takada, C. Crouse, et al., "VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site," Cell, 6:577-84, 1990.

Mariano J. Elices (Dana-Farber Cancer Institute, Boston): "The ability of leukocytes to migrate through the body is an essential underpinning for normal immune surveillance and relies on a dynamic interaction between circulating leukocytes and the endothelium. The leukocyte integrin VLA-4 acts as a cell-surface receptor for the endothelial cell adhesion molecule VCAM-1, which becomes expressed in response to inflammatory cytokines such as interleukin-1 and tumor necrosis factor a. Consequently, mononuclear leukocytes are normally recruited in large numbers to sites of `activated' endothelium during inflammation, and abnormally in certain diseases. Other investigators have shown that VLA-4/VCAM-1 may contribute to the extravasation of some blood-borne tumor cells prior to metastasis. In addition, eosinophil infiltration may involve binding of eosinophil VLA-4 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide